FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953425596> ?p ?o ?g. }

• W2953425596 endingPage "2277" @default.
• W2953425596 startingPage "2277" @default.
• W2953425596 abstract "Abstract Background: We recently presented the feasibility of single circulating tumor cell (CTC) analysis using the QIAscout single cell isolation platform (QIAGEN), followed by whole transcriptome amplification (WTA) and targeted Next Generation Sequencing (NGS). We here applied this workflow in blood samples of patients (pts) with metastatic breast cancer (MBC) and primary ovarian cancer (POC) and compared the result with a new workflow for single cell transcriptome analysis applying the QIAseq UPX 3' Transcriptome Kit (QIAGEN) for high throughput gene expression analysis. Methods: 5 ml blood of 7 MBC and 3 POC pts were analyzed for CTCs using the AdnaTest EMT2/StemCell SelectTM, followed single cell isolation. Adhesion of CTCs to the QIAscout array microrafts was supported by pre-treating the array with Corning® Cell-TakTM Adhesive. Single CTCs have been identified utilizing an inverted microscope, and isolated with the QIAscout single cell isolation platform. Subsequently, mRNA of single cells was amplified by WTA (REPLI-g WTA Single Cell Kit, QIAGEN) and cDNA of the cells was further analyzed by targeted NGS using a QIAseq™ Targeted RNA Panel (Human Cancer Transcriptome Panel, 395 genes). Applying the QIAseq UPX 3' Transcriptome Kit, each single cell was tagged with an individual cell ID-sequence and each RNA molecule was simultaneously tagged with an unique molecular index (UMI) during reverse transcription. Tagging of each individual cDNA molecule enabled pooling of all samples for subsequent amplification and library preparation steps, followed by high-throughput NGS. Methods were validated in spike-in experiments using different cell lines spiked into blood of healthy donors. Results: Using the QIAscout in combination with the WTA-workflow, we have already demonstrated an absent leukocyte contamination. However, only a very few of the detected cells in MBC pts (15%) were finally applicable for NGS. Nevertheless, analyzable CTCs expressed genes involved in angiogenesis (ITGB3), cell cycle (CCND2) and apoptosis (FASLG & SKP2). Applying the UPX 3' Transcriptome-workflow, the number of analyzable CTCs could be markedly improved as documented in spike-in experiments as well as in blood samples of MBC and POC pts. Up to now, in the latter group, we were able to isolate a total number of 84 CTCs [median 25 CTCs (range 24-35 cells)] with 44/84 (52%) ID-sequences detected, being applicable for NGS. Experiments and detailed transcriptome profiling of CTCs are ongoing to be presented at the meeting. Conclusion: Although both described workflows have to be further evaluated in more detail, the QIAscout single cell isolation platform allows subsequent transcriptome analysis followed by NGS to get insights into single cell heterogeneity for further therapeutic strategies. Citation Format: Janina Levermann, Norbert Hochstein, Paul Buderath, Benjamin Franken, Siegfried Hauch, Charline Bemmann, Rainer Kimmig, Sabine Kasimir-Bauer. Workflow evaluation for molecular characterization of single circulating tumor cells in blood samples of patients with gynecological malignancies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2277." @default.
• W2953425596 created "2019-07-12" @default.
• W2953425596 creator A5003887595 @default.
• W2953425596 creator A5006753131 @default.
• W2953425596 creator A5037682627 @default.
• W2953425596 creator A5051059333 @default.
• W2953425596 creator A5052434013 @default.
• W2953425596 creator A5077575151 @default.
• W2953425596 creator A5078507527 @default.
• W2953425596 creator A5091078538 @default.
• W2953425596 date "2019-07-01" @default.
• W2953425596 modified "2023-09-27" @default.
• W2953425596 title "Abstract 2277: Workflow evaluation for molecular characterization of single circulating tumor cells in blood samples of patients with gynecological malignancies" @default.
• W2953425596 doi "https://doi.org/10.1158/1538-7445.am2019-2277" @default.
• W2953425596 hasPublicationYear "2019" @default.
• W2953425596 type Work @default.
• W2953425596 sameAs 2953425596 @default.
• W2953425596 citedByCount "0" @default.
• W2953425596 crossrefType "journal-article" @default.
• W2953425596 hasAuthorship W2953425596A5003887595 @default.
• W2953425596 hasAuthorship W2953425596A5006753131 @default.
• W2953425596 hasAuthorship W2953425596A5037682627 @default.
• W2953425596 hasAuthorship W2953425596A5051059333 @default.
• W2953425596 hasAuthorship W2953425596A5052434013 @default.
• W2953425596 hasAuthorship W2953425596A5077575151 @default.
• W2953425596 hasAuthorship W2953425596A5078507527 @default.
• W2953425596 hasAuthorship W2953425596A5091078538 @default.
• W2953425596 hasConcept C104317684 @default.
• W2953425596 hasConcept C112190416 @default.
• W2953425596 hasConcept C121608353 @default.
• W2953425596 hasConcept C1491633281 @default.
• W2953425596 hasConcept C150194340 @default.
• W2953425596 hasConcept C153911025 @default.
• W2953425596 hasConcept C162317418 @default.
• W2953425596 hasConcept C187882448 @default.
• W2953425596 hasConcept C2776950831 @default.
• W2953425596 hasConcept C2779013556 @default.
• W2953425596 hasConcept C54355233 @default.
• W2953425596 hasConcept C61238886 @default.
• W2953425596 hasConcept C67705224 @default.
• W2953425596 hasConcept C70721500 @default.
• W2953425596 hasConcept C86803240 @default.
• W2953425596 hasConceptScore W2953425596C104317684 @default.
• W2953425596 hasConceptScore W2953425596C112190416 @default.
• W2953425596 hasConceptScore W2953425596C121608353 @default.
• W2953425596 hasConceptScore W2953425596C1491633281 @default.
• W2953425596 hasConceptScore W2953425596C150194340 @default.
• W2953425596 hasConceptScore W2953425596C153911025 @default.
• W2953425596 hasConceptScore W2953425596C162317418 @default.
• W2953425596 hasConceptScore W2953425596C187882448 @default.
• W2953425596 hasConceptScore W2953425596C2776950831 @default.
• W2953425596 hasConceptScore W2953425596C2779013556 @default.
• W2953425596 hasConceptScore W2953425596C54355233 @default.
• W2953425596 hasConceptScore W2953425596C61238886 @default.
• W2953425596 hasConceptScore W2953425596C67705224 @default.
• W2953425596 hasConceptScore W2953425596C70721500 @default.
• W2953425596 hasConceptScore W2953425596C86803240 @default.
• W2953425596 hasIssue "13_Supplement" @default.
• W2953425596 hasLocation W29534255961 @default.
• W2953425596 hasOpenAccess W2953425596 @default.
• W2953425596 hasPrimaryLocation W29534255961 @default.
• W2953425596 hasRelatedWork W1978290629 @default.
• W2953425596 hasRelatedWork W2230726359 @default.
• W2953425596 hasRelatedWork W2313329151 @default.
• W2953425596 hasRelatedWork W2379754400 @default.
• W2953425596 hasRelatedWork W2530589656 @default.
• W2953425596 hasRelatedWork W3046385446 @default.
• W2953425596 hasRelatedWork W3105774516 @default.
• W2953425596 hasRelatedWork W3212902699 @default.
• W2953425596 hasRelatedWork W4206912673 @default.
• W2953425596 hasRelatedWork W4296701617 @default.
• W2953425596 hasVolume "79" @default.
• W2953425596 isParatext "false" @default.
• W2953425596 isRetracted "false" @default.
• W2953425596 magId "2953425596" @default.
• W2953425596 workType "article" @default.